As of 2:06pm ET
| -0.0061 / -2.05%|
The 1 analysts offering 12-month price forecasts for Galena Biopharma Inc have a median target of 4.00, with a high estimate of 4.00 and a low estimate of 4.00. The median estimate represents a +1,261.24% increase from the last price of 0.29.
The current consensus among 2 polled investment analysts is to Hold stock in Galena Biopharma Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.